Aigen Investment Management LP Increases Position in Bath & Body Works, Inc. (NYSE:BBWI)

Aigen Investment Management LP lifted its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 746.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 97,582 shares of the company's stock after buying an additional 86,058 shares during the quarter. Bath & Body Works comprises 0.7% of Aigen Investment Management LP's portfolio, making the stock its 14th largest position. Aigen Investment Management LP's holdings in Bath & Body Works were worth $3,783,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently modified their holdings of BBWI. FMR LLC increased its position in shares of Bath & Body Works by 17,496.5% during the third quarter. FMR LLC now owns 2,516,127 shares of the company's stock valued at $80,315,000 after buying an additional 2,501,828 shares during the period. KBC Group NV grew its holdings in Bath & Body Works by 9,023.5% in the third quarter. KBC Group NV now owns 1,701,813 shares of the company's stock worth $54,322,000 after purchasing an additional 1,683,160 shares during the period. Erste Asset Management GmbH purchased a new stake in Bath & Body Works in the third quarter worth about $50,483,000. Senvest Management LLC purchased a new stake in Bath & Body Works in the third quarter worth about $30,537,000. Finally, Principal Financial Group Inc. grew its holdings in Bath & Body Works by 328.7% in the third quarter. Principal Financial Group Inc. now owns 1,069,941 shares of the company's stock worth $34,153,000 after purchasing an additional 820,379 shares during the period. Hedge funds and other institutional investors own 95.14% of the company's stock.

Remove Ads

Bath & Body Works Stock Down 4.5 %

BBWI traded down $1.54 during trading on Friday, hitting $32.66. The company's stock had a trading volume of 4,652,756 shares, compared to its average volume of 3,886,149. Bath & Body Works, Inc. has a one year low of $26.20 and a one year high of $52.99. The firm has a market cap of $7.07 billion, a PE ratio of 7.97, a P/E/G ratio of 0.92 and a beta of 1.89. The business's 50 day simple moving average is $37.37 and its 200-day simple moving average is $34.18.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping the consensus estimate of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.78 billion. Equities research analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were given a $0.20 dividend. The ex-dividend date was Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.45%. Bath & Body Works's payout ratio is presently 21.98%.

Bath & Body Works announced that its Board of Directors has initiated a share buyback program on Thursday, February 27th that permits the company to repurchase $500.00 million in shares. This repurchase authorization permits the company to repurchase up to 6.4% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's board of directors believes its stock is undervalued.

Wall Street Analyst Weigh In

BBWI has been the topic of a number of recent research reports. Raymond James restated an "outperform" rating and issued a $46.00 price objective (up previously from $42.00) on shares of Bath & Body Works in a report on Tuesday, February 25th. JPMorgan Chase & Co. set a $47.00 price objective on shares of Bath & Body Works in a report on Thursday, February 27th. Argus restated a "hold" rating on shares of Bath & Body Works in a report on Friday, January 10th. Morgan Stanley dropped their target price on shares of Bath & Body Works from $51.00 to $48.00 and set an "overweight" rating on the stock in a research note on Thursday, November 21st. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a "buy" rating in a research note on Tuesday, November 26th. Five research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Bath & Body Works currently has an average rating of "Moderate Buy" and an average target price of $45.06.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.